These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16835400

  • 1. The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
    Zanchi A, Perregaux C, Maillard M, Cefai D, Nussberger J, Burnier M.
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1228-34. PubMed ID: 16835400
    [Abstract] [Full Text] [Related]

  • 2. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Mutoh S.
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [Abstract] [Full Text] [Related]

  • 3. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z, Kramer HJ, Vanourková Z, Cervenka L.
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [Abstract] [Full Text] [Related]

  • 4. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
    Gaikwad AB, Viswanad B, Ramarao P.
    Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
    [Abstract] [Full Text] [Related]

  • 5. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H, Takeshita S, Yamamoto T, Mabuchi M, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Ita M, Mutoh S.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):182-90. PubMed ID: 16039648
    [Abstract] [Full Text] [Related]

  • 6. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell.
    Imanishi T, Kobayashi K, Kuroi A, Ikejima H, Akasaka T.
    Hypertens Res; 2008 Apr 05; 31(4):757-65. PubMed ID: 18633188
    [Abstract] [Full Text] [Related]

  • 7. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
    Laurent D, Gounarides JS, Gao J, Boettcher BR.
    Diabetes Obes Metab; 2009 Jun 05; 11(6):632-6. PubMed ID: 19175377
    [Abstract] [Full Text] [Related]

  • 8. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY, Shen ZF, Chen YT, Sun SJ, Liu Q, Xie MZ.
    Acta Pharmacol Sin; 2005 May 05; 26(5):575-80. PubMed ID: 15842776
    [Abstract] [Full Text] [Related]

  • 9. Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.
    Imanishi T, Kuroi A, Ikejima H, Kobayashi K, Mochizuki S, Goto M, Yoshida K, Akasaka T.
    Hypertens Res; 2008 Jan 05; 31(1):117-25. PubMed ID: 18360026
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL.
    Clin Exp Pharmacol Physiol; 2008 Jan 05; 35(1):72-7. PubMed ID: 18047631
    [Abstract] [Full Text] [Related]

  • 11. A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
    Henriksen K, Byrjalsen I, Nielsen RH, Madsen AN, Larsen LK, Christiansen C, Beck-Nielsen H, Karsdal MA.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):340-5. PubMed ID: 19595686
    [Abstract] [Full Text] [Related]

  • 12. Low birth weight in response to salt restriction during pregnancy is not due to alterations in uterine-placental blood flow or the placental and peripheral renin-angiotensin system.
    Leandro SM, Furukawa LN, Shimizu MH, Casarini DE, Seguro AC, Patriarca G, Coelho MS, Dolnikoff MS, Heimann JC.
    Physiol Behav; 2008 Sep 03; 95(1-2):145-51. PubMed ID: 18572207
    [Abstract] [Full Text] [Related]

  • 13. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.
    Eur J Pharmacol; 2008 Apr 14; 584(1):192-201. PubMed ID: 18346728
    [Abstract] [Full Text] [Related]

  • 14. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z, Ye P, Long C, Chen K, Li X, Wang H.
    Pharmacology; 2007 Apr 14; 79(3):184-92. PubMed ID: 17356310
    [Abstract] [Full Text] [Related]

  • 15. High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.
    Min Q, Bai YT, Jia G, Wu J, Xiang JZ.
    Exp Mol Pathol; 2010 Feb 14; 88(1):133-7. PubMed ID: 19796634
    [Abstract] [Full Text] [Related]

  • 16. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A, Wu L, Wang R, de Champlain J.
    Am J Hypertens; 2006 Apr 14; 19(4):407-12. PubMed ID: 16580578
    [Abstract] [Full Text] [Related]

  • 17. [Effects of high salt diet on blood pressure, renal morphology and osteopontin expression in Sprague-Dawley rat with Ang II-induced renal injury].
    Zheng Y, Liu ZQ, Ye T, He L, Wang Y, Fang Y, Li JN, Liu P, Ye F.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul 14; 25(7):827-32. PubMed ID: 16027079
    [Abstract] [Full Text] [Related]

  • 18. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun 14; 7(2):74-86. PubMed ID: 17083061
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
    Yang R, Smolders I, De Bundel D, Fouyn R, Halberg M, Demaegdt H, Vanderheyden P, Dupont AG.
    J Hypertens; 2008 May 14; 26(5):998-1007. PubMed ID: 18398343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.